Title Credit Type Event date Cost
Successes and Challenges with Chimeric Antigen Receptor T-Cell Therapy
    • 1.00 ACPE - Pharmacist
    • 1.00 AMA
    • 1.00 ANCC
    • 1.00 Attendance
    • 1.00 CCMC - General
    • 1.00 ACPE - Pharmacy Technician
Enduring $0.00
Big Data: Integrated Cancer Information for Population-Based Research
    • 1.00 ACPE - Pharmacist
    • 1.00 AMA
    • 1.00 ANCC
    • 1.00 Attendance
    • 1.00 CCMC - General
    • 1.00 ACPE - Pharmacy Technician
Enduring $0.00
Chimeric Antigen Receptor T-Cell Therapy: A Cure for Cancer?
    • 1.00 ACPE - Pharmacist
    • 1.00 ACPE - Pharmacy Technician
    • 1.00 AMA
    • 1.00 ANCC
    • 1.00 Attendance
    • 1.00 CCMC - General
Enduring $0.00
Best Practices and Emerging Therapies for Myelodysplastic Syndromes (MDS)
    • 1.00 ACPE - Pharmacist
    • 1.00 ACPE - Pharmacy Technician
    • 1.00 AMA
    • 1.00 ANCC
    • 1.00 Attendance
    • 1.00 CCMC - General
Enduring $0.00
Prostate Cancer: Guideline Recommendations and Emerging Therapies
    • 1.00 ACPE - Pharmacist
    • 1.00 ACPE - Pharmacy Technician
    • 1.00 AMA
    • 1.00 ANCC
    • 1.00 Attendance
    • 1.00 CCMC - General
Enduring $0.00
Chimeric Antigen Receptor (CAR) T-cell Therapy
    • 1.00 ACPE - Pharmacist
    • 1.00 ACPE - Pharmacy Technician
    • 1.00 AMA
    • 1.00 ANCC
    • 1.00 Attendance
    • 1.00 CCMC - General
Enduring $0.00
Colorectal Cancer: Screening Guidelines and Genetic Biomarker Testing
    • 1.00 ACPE - Pharmacist
    • 1.00 ACPE - Pharmacy Technician
    • 1.00 AMA
    • 1.00 ANCC
    • 1.00 Attendance
    • 1.00 CCMC - General
Enduring $0.00
Multiple Myeloma: What’s New in Treatment Options
    • 1.00 ACPE - Pharmacist
    • 1.00 ACPE - Pharmacy Technician
    • 1.00 AMA
    • 1.00 ANCC
    • 1.00 Attendance
    • 1.00 CCMC - General
Enduring $0.00
Hepatocellular Carcinoma: Treatment Options Outside of Transplant
    • 1.00 ACPE - Pharmacist
    • 1.00 ACPE - Pharmacy Technician
    • 1.00 AMA
    • 1.00 ANCC
    • 1.00 Attendance
    • 1.00 CCMC - General
Enduring $0.00
Acute Myelogenous Leukemia: New Therapies after 40 Years!
    • 1.00 ACPE - Pharmacist
    • 1.00 ACPE - Pharmacy Technician
    • 1.00 AMA
    • 1.00 ANCC
    • 1.00 Attendance
    • 1.00 CCMC - General
Enduring $0.00
CAR T-cell Therapy: A Personalized Immunotherapy Approach to Cancer
    • 1.00 ACPE - Pharmacist
    • 1.00 ACPE - Pharmacy Technician
    • 1.00 AMA
    • 1.00 ANCC
    • 1.00 Attendance
    • 1.00 CCMC - General
Enduring $0.00
The CAR T-cell Therapy Tsunami: Emerging Therapies and Barriers to Access
    • 1.00 ACPE - Pharmacist
    • 1.00 ACPE - Pharmacy Technician
    • 1.00 AMA
    • 1.00 ANCC
    • 1.00 APA
    • 1.00 ASWB
    • 1.00 Attendance
    • 1.00 CCMC - General
Enduring $0.00
Value in Cancer Care: Finding the Path to Progress
    • 1.00 ACPE - Pharmacist
    • 1.00 ACPE - Pharmacy Technician
    • 1.00 AMA
    • 1.00 ANCC
    • 1.00 APA
    • 1.00 ASWB
    • 1.00 Attendance
    • 1.00 CCMC - General
Enduring $0.00
The Case for Community-based, High-Risk Women’s Cancer Programs
    • 1.00 ACPE - Pharmacist
    • 1.00 ACPE - Pharmacy Technician
    • 1.00 AMA
    • 1.00 ANCC
    • 1.00 APA
    • 1.00 ASWB
    • 1.00 Attendance
    • 1.00 CCMC - General
Enduring $0.00
Cancer Survivorship: A Personalized Precision Approach
    • 1.00 ACPE - Pharmacist
    • 1.00 ACPE - Pharmacy Technician
    • 1.00 AMA
    • 1.00 ANCC
    • 1.00 APA
    • 1.00 ASWB
    • 1.00 Attendance
    • 1.00 CCMC - General
Enduring $0.00

Pages